Quadrant Capital Group LLC Nektar Therapeutics Transaction History

Quadrant Capital Group LLC

$1.43 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$3.04 - $5.14 $158 - $267	52 Added 14.57%	409 $1,000
Q2 2022 Aug 09, 2022	SELL	$3.17 - $6.17 $10,191 - $19,836	-3,215 Reduced 90.01%	357 $1,000
Q1 2022 May 06, 2022	BUY	$4.16 - $13.72 $10,416 - $34,354	2,504 Added 234.46%	3,572 $19,000
Q4 2021 Feb 01, 2022	BUY	$10.83 - $18.41 $9,043 - $15,372	835 Added 358.37%	1,068 $14,000
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $993 - $1,431	76 Added 48.41%	233 $4,000
Q2 2021 Aug 09, 2021	BUY	$16.52 - $20.4 $49 - $61	3 Added 1.95%	157 $3,000
Q1 2021 May 12, 2021	BUY	$16.56 - $25.46 $563 - $865	34 Added 28.33%	154 $3,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $2,759 - $3,330	-175 Reduced 59.32%	120 $2,000
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $1,410 - $2,107	-85 Reduced 22.37%	295 $5,000
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $17,517 - $24,354	-1,039 Reduced 73.22%	380 $9,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $781 - $1,509	-54 Reduced 3.67%	1,419 $24,000
Q4 2019 Feb 03, 2020	BUY	$15.87 - $23.12 $2,602 - $3,791	164 Added 12.53%	1,473 $28,000
Q3 2019 Oct 24, 2019	SELL	$16.91 - $36.27 $11,718 - $25,135	-693 Reduced 34.62%	1,309 $22,000
Q2 2019 Jul 24, 2019	BUY	$31.0 - $36.3 $56,389 - $66,029	1,819 Added 993.99%	2,002 $69,000
Q4 2018 Jan 17, 2019	BUY	$30.43 - $56.65 $547 - $1,019	18 Added 10.91%	183 $4,000
Q3 2018 Oct 29, 2018	SELL	$46.46 - $68.49 $7,526 - $11,095	-162 Reduced 49.54%	165 $9,000
Q2 2018 Aug 09, 2018	SELL	$46.25 - $104.45 $3,468 - $7,833	-75 Reduced 18.66%	327 $14,000
Q1 2018 May 10, 2018	BUY	$57.4 - $108.44 $11,939 - $22,555	208 Added 107.22%	402 $40,000
Q3 2017 Oct 13, 2017	BUY	$17.79 - $24.0 $1,618 - $2,184	91 Added 88.35%	194 $4,000
Q2 2017 Aug 15, 2017	BUY	N/A	103	103 $0

Others Institutions Holding NKTR

# of Institutions

152

Shares Held

131M

Call Options Held

92.7K

Put Options Held

4.9K

Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.3M
Shares

$11.5 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.67M
Shares

$8.99 Million
0.14% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

7.81M
Shares

$7.26 Million
0.37% of portfolio
Acadian Asset Management LLC Boston, MA

7.2M
Shares

$6.7 Million
0.02% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account